These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 37649350)
1. Identifying and addressing unmet clinical needs in primary cutaneous B-cell lymphoma: A consensus-based paper from an ad-hoc international panel. Quaglino P; Pimpinelli N; Zinzani PL; Paulli M; Pileri S; Berti E; Cerroni L; Guitart J; Kim YH; Rupoli S; Santucci M; Simontacchi G; Vermeer M; Hoppe R; Pro B; Swerdlow SH; Barosi G Hematol Oncol; 2024 Jan; 42(1):e3215. PubMed ID: 37649350 [TBL] [Abstract][Full Text] [Related]
2. Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management. Fava P; Roccuzzo G; Alberti-Violetti S; Grandi V; Pileri A; Pimpinelli N; Berti E; Quaglino P Presse Med; 2022 Mar; 51(1):104109. PubMed ID: 35026390 [TBL] [Abstract][Full Text] [Related]
3. European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas. Senff NJ; Noordijk EM; Kim YH; Bagot M; Berti E; Cerroni L; Dummer R; Duvic M; Hoppe RT; Pimpinelli N; Rosen ST; Vermeer MH; Whittaker S; Willemze R; ; Blood; 2008 Sep; 112(5):1600-9. PubMed ID: 18567836 [TBL] [Abstract][Full Text] [Related]
4. Primary cutaneous B-cell lymphomas: recent advances in diagnosis and management. Sokol L; Naghashpour M; Glass LF Cancer Control; 2012 Jul; 19(3):236-44. PubMed ID: 22710899 [TBL] [Abstract][Full Text] [Related]
5. Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas. Krenitsky A; Klager S; Hatch L; Sarriera-Lazaro C; Chen PL; Seminario-Vidal L Am J Clin Dermatol; 2022 Sep; 23(5):689-706. PubMed ID: 35854102 [TBL] [Abstract][Full Text] [Related]
7. Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. Haverkos B; Tyler K; Gru AA; Winardi FK; Frederickson J; Hastings J; Elkins C; Zhang X; Xu-Welliver M; Wong HK; Porcu P Oncologist; 2015 Oct; 20(10):1161-6. PubMed ID: 26306900 [TBL] [Abstract][Full Text] [Related]
8. Unmet clinical needs in the use of zanubrutinib in malignant lymphomas (Waldenström macroglobulinemia, marginal zone lymphoma and mantle cell lymphoma): A consensus-based position paper from an ad hoc expert panel. Zinzani PL; Mauro FR; Tedeschi A; Varettoni M; Zaja F; Barosi G Hematol Oncol; 2023 Dec; 41(5):795-808. PubMed ID: 37165730 [TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous B-cell lymphomas: a practical approach. Demierre MF; Kerl H; Willemze R Hematol Oncol Clin North Am; 2003 Dec; 17(6):1333-50. PubMed ID: 14710888 [TBL] [Abstract][Full Text] [Related]
11. Critical concepts and management recommendations for cutaneous T-cell lymphoma: A consensus-based position paper from the Italian Group of Cutaneous Lymphoma. Zinzani PL; Quaglino P; Violetti SA; Cantonetti M; Goteri G; Onida F; Paulli M; Rupoli S; Barosi G; Pimpinelli N Hematol Oncol; 2021 Aug; 39(3):275-283. PubMed ID: 33855728 [TBL] [Abstract][Full Text] [Related]
12. Primary cutaneous B-cell lymphomas. Current concepts. I. Santucci M; Pimpinelli N Haematologica; 2004 Nov; 89(11):1360-71. PubMed ID: 15531459 [TBL] [Abstract][Full Text] [Related]
19. Standard and new treatments in cutaneous B-cell lymphomas. Dreno B J Cutan Pathol; 2006 Feb; 33 Suppl 1():47-51. PubMed ID: 16412212 [TBL] [Abstract][Full Text] [Related]
20. Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel. Zinzani PL; Paulli M; Arcaini L; Della Torre E; Ferrero S; Figuera A; Frigeri F; Martelli M; Sabattini E; Scarpa R; Barosi G Hemasphere; 2023 Jun; 7(6):e891. PubMed ID: 37234822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]